We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biodel Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject™ and Plans Manufacturing Facility for VIAject™

News   Jan 08, 2008

 
Biodel Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject™ and Plans Manufacturing Facility for VIAject™
 
 
 

RELATED ARTICLES

Plug-and-Play Technology Automates Chemical Synthesis

News

MIT researchers have now developed an automated chemical synthesis system that can take over many of the more tedious aspects of chemical experimentation, freeing up chemists to spend more time on the more analytical and creative aspects of their research.

READ MORE

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Better Tailored Drugs with Fewer Side-Effects

News

A recent achievement in the field of protein research allows for better tailored pharmaceuticals with fewer side-effects.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE